FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas.

作者: B Mann , A Gratchev , C Böhm , M L Hanski , H D Foss

DOI: 10.1038/SJ.BJC.6690202

关键词:

摘要: Colorectal carcinoma cells have recently been shown to express Fas ligand (FasL). This could allow the tumour evade activated tumour-infiltrating lymphocytes (TILs) by inducing their apoptosis and would thus promote survival possibly metastasis formation. To test this hypothesis in vivo we analysed expression of FasL mRNA protein paired tissue samples normal colonic mucosa (N), primary colorectal carcinomas (T) metastases (M) from a total 21 patients four different methods. Additionally, presence activation status infiltrating lymphocytes, which might contribute amount tissue, was determined semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) same samples. The frequency detection 30-40% T 60-100% M, depending on sensitivity method. Simultaneously, CD25 mRNA, used as measure number TILs, 90% lower M than T. increased liver therefore not due TILs. We conclude that metastasizing subpopulations more frequently may be able eliminate TILs via Fas/FasL-induced or other hitherto unknown mechanisms.

参考文章(33)
Stephan Ehl, Rolf Zinkernagel, Hans Hengartner, Shigekazu Nagata, Urs Hoffmann-Rohrer, Different susceptibility of cytotoxic T cells to CD95 (Fas/Apo-1) ligand-mediated cell death after activation in vitro versus in vivo. Journal of Immunology. ,vol. 156, pp. 2357- 2360 ,(1996)
P Saas, P R Walker, P Y Dietrich, Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back Journal of Immunology. ,vol. 158, pp. 4521- 4524 ,(1997)
Shoji Oda, Shigekazu Nagata, Shunichi Miyazaki, Yoko Oshimi, Yoshiko Honda, Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. Journal of Immunology. ,vol. 157, pp. 2909- 2915 ,(1996)
T. S. Griffith, T. Brunner, S. M. Fletcher, D. R. Green, T. A. Ferguson, Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege Science. ,vol. 270, pp. 1189- 1192 ,(1995) , 10.1126/SCIENCE.270.5239.1189
L E French, M Hahne, I Viard, G Radlgruber, R Zanone, K Becker, C Müller, J Tschopp, Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. Journal of Cell Biology. ,vol. 133, pp. 335- 343 ,(1996) , 10.1083/JCB.133.2.335
Jens Dhein, Henning Walczak, Caroline Bäumler, Klaus-Michael Debatin, Peter H. Krammer, Autocrine T-cell suicide mediated by APO-1/(Fas/CD95) Nature. ,vol. 373, pp. 438- 441 ,(1995) , 10.1038/373438A0
R De Maria, M Boirivant, M G Cifone, P Roncaioli, M Hahne, J Tschopp, F Pallone, A Santoni, R Testi, Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes. A potential role for the acidic sphingomyelinase pathway in normal immunoregulation. Journal of Clinical Investigation. ,vol. 97, pp. 316- 322 ,(1996) , 10.1172/JCI118418
M. Hahne, D. Rimoldi, M. Schroter, P. Romero, M. Schreier, L. E. French, P. Schneider, T. Bornand, A. Fontana, D. Lienard, J.-C. Cerottini, J. Tschopp, Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape Science. ,vol. 274, pp. 1363- 1366 ,(1996) , 10.1126/SCIENCE.274.5291.1363